Table 1.
Generation of renal disease in recipient mice by the transfer of DOCK8+CD4 T cells
Donor | Transferred cell | Lupus nephritis WHO class |
|||
---|---|---|---|---|---|
I & II | III | IV | V | ||
12x PBS | CD4 T cell | 71.96 ±11.04% | 28.03 ±11.04% | 0% | 0% |
12x OVA | DOCK8- CD4 T cell | 68.54 ±12.39% | 29.31 ±12.75% | 2.14 ±3.36% | 0% |
12x OVA | DOCK8+ CD4 T cell | 18.77 ±9.40%∗∗ | 33.99 ±9.78% | 31.89 ±17.04%∗ | 15.32 ±9.17%∗ |
Glomerulonephritis in BALB/c mice that had been pre-immunized 8x with OVA, depleted of CD4 T cells by anti-CD4 Ab, and inoculated with DOCK8−CD4 T cells or DOCK8+CD4 T cells from 12x OVA-immunized BALB/c mice. Control group was BALB/c mice that had been pre-immunized 8x with OVA, depleted of CD4 T cells by anti-CD4 Ab, and inoculated with CD4 T cells from 12x PBS-immunized BALB/c mice. Glomerular lesions in mice were classified according to human WHO classification (Weening et al., 2004) as follows; class I, normal glomeruli; class II, purely mesangial disease; class III, focal proliferative glomerulonephritis; class IV, diffuse proliferative glomerulonephritis; and class V, membraneous glomerulonephritis. Data were represented as mean ± SEM. Statistical assessment was by Student's t-test.
p<0.05,vis 12x OVA DOCK8- CD4 T cell and vis 12x PBS CD4 T cell.
p<0.001, vis 12x OVA DOCK8- CD4 T cell and vis 12x PBS CD4 T cell.